A case-series study to determine clinical outcomes of Inotuzumab ozogamicin in infants and young children with relapsed or refractory acute lymphoblastic leukaemia
Latest Information Update: 13 Oct 2021
At a glance
- Drugs Inotuzumab ozogamicin (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 13 Oct 2021 New trial record